929074-42-0 Usage
General Description
5-Chloro-3,4-diaminopyridine is a chemical compound with the molecular formula C5H6ClN3. It is a chlorinated derivative of 3,4-diaminopyridine and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 5-Chloro-3,4-diaminopyridine is also known for its use in organic synthesis and as a reagent in chemical reactions. It is a white to off-white solid that is soluble in water and organic solvents. 5-Chloro-3,4-diaminopyridine is known for its ability to act as a catalyst and for its role in the production of various compounds in the pharmaceutical and agricultural industries. Overall, it is a valuable chemical that has multiple uses in different fields of chemistry and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 929074-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,0,7 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 929074-42:
(8*9)+(7*2)+(6*9)+(5*0)+(4*7)+(3*4)+(2*4)+(1*2)=190
190 % 10 = 0
So 929074-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H6ClN3/c6-3-1-9-2-4(7)5(3)8/h1-2H,7H2,(H2,8,9)
929074-42-0Relevant articles and documents
4 - SUBSTITUTED 1, 3 - DIHYDRO - 2H - BENZIMIDAZOL - 2 - ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
-
Page/Page column 51; 53, (2014/01/08)
The present invention is concerned with novel 4-substituted 1,3-dihydro-2H- benzimidazol-2-one derivatives substituted with benzimidazoles having formula (I), tautomers and stereoisomeric forms thereof, and the pharmaceutically acceptable addition salts, and the solvates thereof, wherein R4, R5, Z and Het have the meaning defined in the claims. The compounds according to the present invention are useful as inhibitors on the replication of the respiratory syncytial virus (RSV). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.
